PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 15, Issue 6, Pages 758-767
Publisher
Informa UK Limited
Online
2014-03-21
DOI
10.4161/cbt.28553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)
- (2013) Kevin C. De Braganca et al. Current Treatment Options in Neurology
- Expression of heat shock proteins in medulloblastoma
- (2013) George A. Alexiou et al. Journal of Neurosurgery-Pediatrics
- Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis
- (2013) Yong Wang et al. PLoS One
- Evaluation of PDE5 and PDE9 Expression in Benign and Malignant Breast Tumors
- (2012) Fatemeh Karami-Tehrani et al. ARCHIVES OF MEDICAL RESEARCH
- PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter
- (2012) Jun-Jiang Chen et al. CANCER SCIENCE
- The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease
- (2012) Erin K. Daugherity et al. CELL CYCLE
- Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells
- (2012) Z. Korwek et al. DNA REPAIR
- PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cells
- (2012) Xiaodong Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
- (2011) M. D. Bareford et al. CANCER RESEARCH
- Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
- (2010) Margaret A. Park et al. CANCER BIOLOGY & THERAPY
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction
- (2010) A. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice
- (2009) Anindita Das et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
- (2008) G. Zhang et al. CLINICAL CANCER RESEARCH
- Protein Kinase G-dependent Cardioprotective Mechanism of Phosphodiesterase-5 Inhibition Involves Phosphorylation of ERK and GSK3β
- (2008) Anindita Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now